Article

Effectiveness and Safety of MSC Cell Therapies for Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis

2021-09-16

Abstract excerpt

Background: Covid-19 has contributed to high mortality and morbidity among hospitalized patients. One of the main pathophysiological processes of the disease is an exuberant immune response leading to respiratory failure. MSC (a.k.a. mesenchymal stem cell or medicinal signaling cell) cell therapies have shown promise in modulating responses in inflammatory diseases and trend in decreasing mortality in ARDS. Contro...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0110a45b-02ac-5cd4-9c34-23e3f3151bd9
DOI: 10.2139/ssrn.3924851

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Effectiveness and Safety of MSC Cell Therapies for Hospitalized Patients with COVID-19: A Systematic Review and Meta-AnalysisDOI 10.2139/ssrn.3924851Read

The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expectSemantic proximity Read

The Potential Use of Mesenchymal Stem Cells and Their Derived Exosomes as Immunomodulatory Agents for COVID-19 PatientsSemantic proximity Read

Human Umbilical Cord-Derived Mesenchymal Stem Cell Therapy in COVID-19 Patients: A Phase 1 Clinical TrialSemantic proximity Read

Clinical efficacy of sofosbuvir/daclatasvir in patients with COVID-19: a systematic review and meta-analysis of randomized trials.Semantic proximity Read

Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospectsSemantic proximity Read

COVID-19 and its Therapeutics: Special Emphasis on Mesenchymal Stem Cells Based TherapySemantic proximity Read

Combating COVID-19 with mesenchymal stem cell therapySemantic proximity Read

Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatmentSemantic proximity Read

Effectiveness of Molnupiravir for the Treatment of COVID-19: A Systematic Literature Review of Real-World Observational StudiesSemantic proximity Read

Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trialSemantic proximity Read

Human Mesenchymal Stem Cells Treatment for Severe COVID-19: 1-Year Follow-Up Results of a Randomized, Double-Blind, Placebo-Controlled TrialSemantic proximity Read